154 related articles for article (PubMed ID: 22719016)
21. Melatonin and zopiclone as pharmacologic aids to facilitate crew rest.
Paul MA; Brown G; Buguet A; Gray G; Pigeau RA; Weinberg H; Radomski M
Aviat Space Environ Med; 2001 Nov; 72(11):974-84. PubMed ID: 11718517
[TBL] [Abstract][Full Text] [Related]
22. Caffeine does not modulate inhibitory control.
Tieges Z; Snel J; Kok A; Richard Ridderinkhof K
Brain Cogn; 2009 Mar; 69(2):316-27. PubMed ID: 18782649
[TBL] [Abstract][Full Text] [Related]
23. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
Johnson MW; Suess PE; Griffiths RR
Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
Blin O; Micallef J; Audebert C; Legangneux E
J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
[TBL] [Abstract][Full Text] [Related]
25. Midazolam 12 mg is moderately counteracted by 250 mg caffeine in man.
Mattila MJ; Vainio P; Nurminen ML; Vanakoski J; Seppälä T
Int J Clin Pharmacol Ther; 2000 Dec; 38(12):581-7. PubMed ID: 11125871
[TBL] [Abstract][Full Text] [Related]
26. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
Zacny JP; Gutierrez S
Pain Med; 2008; 9(4):433-43. PubMed ID: 18489634
[TBL] [Abstract][Full Text] [Related]
27. The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects.
Liem-Moolenaar M; Zoethout RW; de Boer P; Schmidt M; de Kam ML; Cohen AF; Franson KL; van Gerven JM
J Psychopharmacol; 2010 Nov; 24(11):1681-7. PubMed ID: 19648218
[TBL] [Abstract][Full Text] [Related]
28. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
29. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
30. Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers.
Smith A; Sutherland D; Christopher G
J Psychopharmacol; 2005 Nov; 19(6):620-6. PubMed ID: 16272184
[TBL] [Abstract][Full Text] [Related]
31. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
Lieberman HR; Tharion WJ; Shukitt-Hale B; Speckman KL; Tulley R
Psychopharmacology (Berl); 2002 Nov; 164(3):250-61. PubMed ID: 12424548
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
[TBL] [Abstract][Full Text] [Related]
33. L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.
Andreu N; Chalé JJ; Senard JM; Thalamas C; Montastruc JL; Rascol O
Clin Neuropharmacol; 1999; 22(1):15-23. PubMed ID: 10047929
[TBL] [Abstract][Full Text] [Related]
34. The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects.
Liem-Moolenaar M; Zoethout RW; de Boer P; Schmidt M; de Kam ML; Cohen AF; Franson KL; van Gerven JM
J Psychopharmacol; 2010 Nov; 24(11):1671-9. PubMed ID: 20142308
[TBL] [Abstract][Full Text] [Related]
35. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
Hindmarch ; Shamsi Z
Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401
[TBL] [Abstract][Full Text] [Related]
36. Chlorpheniramine and ephedrine in combination for motion sickness.
Buckey JC; Alvarenga DL; MacKenzie TA
J Vestib Res; 2007; 17(5-6):301-11. PubMed ID: 18626140
[TBL] [Abstract][Full Text] [Related]
37. The influence of placebo awareness on stimulant drug response in a double-blind trial.
Nash JM; Holroyd KA; Rokicki LA; Kvaal S; Penzien DB
Psychopharmacology (Berl); 2002 May; 161(3):213-21. PubMed ID: 12021824
[TBL] [Abstract][Full Text] [Related]
38. Effects of caffeine on anticipatory control processes: evidence from a cued task-switch paradigm.
Tieges Z; Snel J; Kok A; Plat N; Ridderinkhof R
Psychophysiology; 2007 Jul; 44(4):561-78. PubMed ID: 17539921
[TBL] [Abstract][Full Text] [Related]
39. Psychomotor performance: investigating the dose-response relationship for caffeine and theophylline in elderly volunteers.
Bryant CA; Farmer A; Tiplady B; Keating J; Sherwood R; Swift CG; Jackson SH
Eur J Clin Pharmacol; 1998 Jun; 54(4):309-13. PubMed ID: 9696955
[TBL] [Abstract][Full Text] [Related]
40. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.
Theunissen EL; Vermeeren A; Ramaekers JG
Br J Clin Pharmacol; 2006 Jan; 61(1):79-86. PubMed ID: 16390354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
